Sign In
Get Clay Free →

Suggestions

    Nicholas Dracopoli

    Chief Scientific Officer at Delfi Diagnostics

    Nicholas Dracopoli is the Chief Scientific Officer and Co-Founder at Delfi Diagnostics, a company focused on cancer diagnostics.45 He brings over 20 years of experience in the biotech and pharmaceutical industries to his role at Delfi.5

    Professional Background

    Prior to joining Delfi Diagnostics, Dracopoli held leadership positions at several prominent organizations:

    • Personal Genome Diagnostics (PGDx), where he served as Senior Vice President of Translation Science3
    • Janssen
    • Bristol-Myers Squibb5

    Expertise

    Dracopoli's areas of expertise include:

    • Pharmaceutical industry
    • Biotechnology
    • Life sciences2

    Education and Connections

    Nicholas Dracopoli received his education from the University of London.1 He is well-connected in the professional world, with over 500 connections on LinkedIn.1

    Current Role

    At Delfi Diagnostics, Dracopoli plays a key role in the company's mission to develop cancer diagnostic tools. He represents the company at industry events, such as the Maryland Tech Council receptions4, and is involved in the company's growth and development.

    Related Questions

    What are Nicholas Dracopoli's key achievements at Delfi Diagnostics?
    What is Nicholas Dracopoli's educational background?
    How did Nicholas Dracopoli transition from Personal Genome Diagnostics to Delfi Diagnostics?
    What are Nicholas Dracopoli's main responsibilities as Chief Scientific Officer at Delfi Diagnostics?
    What companies has Nicholas Dracopoli worked for before joining Delfi Diagnostics?
    Nicholas Dracopoli
    Nicholas Dracopoli, photo 1
    Nicholas Dracopoli, photo 2
    Get intro to Nicholas
    Add to my network

    Experience

    Chief Scientific Officer at Delfi Diagnostics (June 2019 - Present)
    Senior Vice President, Translational Science at Personal Genome Diagnostics (January 2018 - January 2019) Vice President, Head Oncology Diagnostics at Janssen Pharmaceutical Companies of Johnson & Johnson (January 2017 - December 2017) Vice President, Head Oncology Translational Research at Janssen Pharmaceutical Companies of Johnson & Johnson (November 2007 - December 2016), Vice President, Clinical Discovery Technologies at Bristol-Myers Squibb (April 2002 - November 2007) Executive Director, Clinical Discovery Technologies at Bristol-Myers Squibb (June 2001 - April 2002) Executive Director, Pharmacogenomics & Human Genetics at Bristol-Myers Squibb (September 1999 - June 2001)

    Education

    Doctor of Philosophy (Ph.D.) in Anthropology from University of London (1976 - 1981) Bachelor’s Degree in Botany/Zoology from University of London (1973 - 1976)

    Location

    Washington, District of Columbia, United States

    Tags

    leadershiptechnologyresearchunited statesbachelor's degreeanthropologyoncologywashingtongeneticsuniversity of londondoctor of philosophygenomicsdistrict of columbiadiagnosticsbristol-myers squibbchief scientific officer

    Mutual Connections

    See who you know in common with Nicholas
    Clay can make mistakes, so please verify responses. Data is from public sources. Trademarks are property of their respective owners.
    About Clay

    Tags

    leadershiptechnologyresearchunited statesbachelor's degreeanthropologyoncologywashingtongeneticsuniversity of londondoctor of philosophygenomicsdistrict of columbiadiagnosticsbristol-myers squibbchief scientific officer

    Mutual Connections

    See who you know in common with Nicholas
    Explore your network in depth
    Unlock your full potential with Clay
    Try for free →